Hereditary Angioedema Therapeutics Market Poised for Growth at 16.79% CAGR, Driven by Rising Awareness and Treatment Advancements the global Hereditary Angioedema (HAE) therapeutics market is projected to reach US$ 14.19 billion by 2029, reflecting a robust compound annual growth rate (CAGR) of 16.79%. This press release highlights key findings from a new market report by Maximize Market...